
The best Bull and Bear pitches based on recency and number of recommendations.
Let us count the ways: 1. Developing a treatment for dermal scarring = limited market even if their product does work. (Not guaranteed). 2. Ridiculous P/S and P/B. 3. Spammed by stock promoters 4. In a tail-spin.
Read the most recent pitches from players about PHIO.
Recs
undervalued
Recs
Let us count the ways:
1. Developing a treatment for dermal scarring = limited market even if their product does work. (Not guaranteed).
2. Ridiculous P/S and P/B.
3. Spammed by stock promoters
4. In a tail-spin.
Recs
Biotech gamble, should have added this when I got it 2 years ago at 1.56 Still on its way up, drugs in the pipeline
Find the members with the highest scoring picks in PHIO.
WallSTcz (< 20) Score: +517.02
The Score Leader is the player with the highest score across all their picks in PHIO.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
brianitt | 62.91 | 12/18/2008 |
![]() |
5Y | $851.00 | -99.95% | +328.48% | +428.43 | 0 Comment | |
DMLOUGH | 88.57 | 9/7/2010 |
![]() |
1Y | $195.00 | -99.77% | +246.96% | +346.72 | 0 Comment | |
SheepInvstr321 | 96.24 | 3/11/2010 |
![]() |
5Y | $547.00 | -99.92% | +232.80% | +332.72 | 0 Comment | |
chicachick | 68.44 | 10/1/2010 |
![]() |
5Y | $291.00 | -99.85% | +231.96% | +331.80 | 1 Comment | |
Blew133 | 85.08 | 3/17/2010 |
![]() |
3M | $665.00 | -99.93% | +226.93% | +326.86 | 0 Comment | |
colddrink73 | 91.56 | 4/26/2012 |
![]() |
5Y | $128.50 | -99.65% | +173.87% | +273.52 | 0 Comment | |
headyinvestor | 84.31 | 11/27/2012 |
![]() |
5Y | $162.00 | -99.72% | +170.34% | +270.06 | 0 Comment | |
ChiragJasani | < 20 | 9/13/2012 |
![]() |
3Y | $187.00 | -99.76% | +164.40% | +264.16 | 0 Comment | |
mountaincouger | 27.80 | 2/20/2013 |
![]() |
5Y | $207.00 | -99.78% | +150.06% | +249.84 | 0 Comment | |
julianrh | < 20 | 7/15/2013 |
![]() |
3Y | $187.00 | -99.76% | +127.25% | +227.01 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.